Rosuvastatin was tested in unchallenged and LPS-challenged pure microglia.
It inhibited proliferation and cell adhesion in control microglia.
It inhibited IL-1β, TNF-α synthesis and other pro-inflammatory genes in LPS-treated cells.
It elevated IL-10 production and the expression of other anti-inflammatory genes in both groups.
Rosuvastatin’s effects are beneficial during neuroinflammation.